Systemic steroids in COPD-the beauty and the beast

por Vogelmeier, Claus F
Publicado 2014

Digitalisierung in der Inneren Medizin – aktuelle Entwicklungen

por Vogelmeier, Claus F.
Publicado 2022

Exacerbations of COPD

por Viniol, Christian, Vogelmeier, Claus F.
Publicado 2018

Health status in patients with COPD treated with roflumilast: two large noninterventional real-life studies: DINO and DACOTA

por Kardos, Peter, Mokros, Ingo, Sauer, Rüdiger, Vogelmeier, Claus F
Publicado 2018

Lung Health for All: Chronic Obstructive Lung Disease and World Lung Day 2022

por Halpin, David M. G., Vogelmeier, Claus F., Agusti, Alvar
Publicado 2022

Gold 2023: Highlights for primary care

por Agustí, Alvar, Sisó-Almirall, Antoni, Roman, Miguel, Vogelmeier, Claus F.
Publicado 2023

COPD & COVID-19

por Halpin, David M.G., Vogelmeier, Claus F., Agusti, Alvar A.
Publicado 2021

COPD & COVID-19

por Halpin, David M.G., Vogelmeier, Claus F., Agusti, Alvar A.
Publicado 2021

Excess Costs of Comorbidities in Chronic Obstructive Pulmonary Disease: A Systematic Review

por Huber, Manuel B., Wacker, Margarethe E., Vogelmeier, Claus F., Leidl, Reiner
Publicado 2015

Tiotropium and Salmeterol in COPD Patients at Risk of Exacerbations: A Post Hoc Analysis from POET-COPD(®)

por Vogelmeier, Claus F., Asijee, Guus M., Kupas, Katrin, Beeh, Kai M.
Publicado 2015

Comorbid Influences on Generic Health-Related Quality of Life in COPD: A Systematic Review

por Huber, Manuel B., Wacker, Margarethe E., Vogelmeier, Claus F., Leidl, Reiner
Publicado 2015

Teaching medicine web-based with the help of interactive audience response systems

por Kremer, Phillip, Richter, Leonard, Melms, Leander, Vogelmeier, Claus F., Schaefer, Juergen R.
Publicado 2023

Chronisch-obstruktive Lungenerkrankung 2021 – die richtige Therapie für den richtigen Patienten

por Olschewski, Horst, Buhl, Roland, Funk, Georg Christian, Valipour, Arschang, Vogelmeier, Claus F.
Publicado 2021

COPD Exacerbation History and Impact on Future Exacerbations – 8-Year Retrospective Observational Database Cohort Study from Germany

por Vogelmeier, Claus F, Diesing, Joanna, Kossack, Nils, Pignot, Marc, Friedrich, Felix W
Publicado 2021

Influence of body mass on predicted values of static hyperinflation in COPD

por Alter, Peter, Rabe, Klaus F, Schulz, Holger, Vogelmeier, Claus F, Jörres, Rudolf A
Publicado 2018

Inhaled corticosteroid use by exacerbations and eosinophils: a real-world COPD population

por Vestbo, Jørgen, Vogelmeier, Claus F, Small, Mark, Siddall, James, Fogel, Robert, Kostikas, Konstantinos
Publicado 2019

GOLD 2023 Executive Summary: responses from the GOLD Scientific Committee

por Agustí, Alvar, Anzueto, Antonio, Celli, Bartolome R., Mortimer, Kevin, Salvi, Sundeep, Vogelmeier, Claus F.
Publicado 2023

Real world evaluation of a novel lateral flow assay (AlphaKit® QuickScreen) for the detection of alpha-1-antitrypsin deficiency

por Greulich, Timm, Rodríguez-Frias, Francisco, Belmonte, Irene, Klemmer, Andreas, Vogelmeier, Claus F., Miravitlles, Marc
Publicado 2018

COPD Assessment Test Changes from Baseline Correlate with COPD Exacerbations: A Longitudinal Analysis of the DACCORD Observational Study

por Kardos, Peter, Vogelmeier, Claus F., Worth, Heinrich, Buhl, Roland, Obermoser, Victoria, Criée, Carl-Peter
Publicado 2020

Impact of switching from triple therapy to dual bronchodilation in COPD: the DACCORD ‘real world’ study

por Vogelmeier, Claus F., Worth, Heinrich, Buhl, Roland, Criée, Carl-Peter, Gückel, Eva, Kardos, Peter
Publicado 2022